Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Oxid Med Cell Longev ; 2016: 5213532, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26788248

RESUMEN

Iron and copper release participates in the myocardial injury under ischemic conditions and hence protection might be achieved by iron chelators. Data on copper chelation are, however, sparse. The effect of the clinically used copper chelator D-penicillamine in the catecholamine model of acute myocardial injury was tested in cardiomyoblast cell line H9c2 and in Wistar Han rats. D-Penicillamine had a protective effect against catecholamine-induced injury both in vitro and in vivo. It protected H9c2 cells against the catecholamine-induced viability loss in a dose-dependent manner. In animals, both intravenous D-penicillamine doses of 11 (low) and 44 mg/kg (high) decreased the mortality caused by s.c. isoprenaline (100 mg/kg) from 36% to 14% and 22%, respectively. However, whereas the low D-penicillamine dose decreased the release of cardiac troponin T (specific marker of myocardial injury), the high dose resulted in an increase. Interestingly, the high dose led to a marked elevation in plasma vitamin C. This might be related to potentiation of oxidative stress, as suggested by additional in vitro experiments with D-penicillamine (iron reduction and the Fenton reaction). In conclusion, D-penicillamine has protective potential against catecholamine-induced cardiotoxicity; however the optimal dose selection seems to be crucial for further application.


Asunto(s)
Cardiotónicos/farmacología , Miocardio/patología , Penicilamina/farmacología , Animales , Cardiotónicos/química , Catecolaminas , Línea Celular , Supervivencia Celular/efectos de los fármacos , Deferoxamina/farmacología , Concentración de Iones de Hidrógeno , Iones , Hierro/metabolismo , Quelantes del Hierro/farmacología , Masculino , Penicilamina/química , Ratas Wistar , Troponina T/metabolismo
2.
Ann Hepatol ; 13(2): 273-83, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24552870

RESUMEN

Spirulina platensis is a blue-green alga used as a dietary supplement because of its hypocholesterolemic properties. Among other bioactive substances, it is also rich in tetrapyrrolic compounds closely related to bilirubin molecule, a potent antioxidant and anti-proliferative agent. The aim of our study was to evaluate possible anticancer effects of S. platensis and S. platensis-derived tetrapyrroles using an experimental model of pancreatic cancer. The anti-proliferative effects of S. platensis and its tetrapyrrolic components [phycocyanobilin (PCB) and chlorophyllin, a surrogate molecule for chlorophyll A] were tested on several human pancreatic cancer cell lines and xenotransplanted nude mice. The effects of experimental therapeutics on mitochondrial reactive oxygen species (ROS) production and glutathione redox status were also evaluated. Compared to untreated cells, experimental therapeutics significantly decreased proliferation of human pancreatic cancer cell lines in vitro in a dose-dependent manner (from 0.16 g•L-1 [S. platensis], 60 µM [PCB], and 125 µM [chlorophyllin], p<0.05). The anti-proliferative effects of S. platensis were also shown in vivo, where inhibition of pancreatic cancer growth was evidenced since the third day of treatment (p < 0.05). All tested compounds decreased generation of mitochondrial ROS and glutathione redox status (p = 0.0006; 0.016; and 0.006 for S. platensis, PCB, and chlorophyllin, respectively). In conclusion, S. platensis and its tetrapyrrolic components substantially decreased the proliferation of experimental pancreatic cancer. These data support a chemopreventive role of this edible alga. Furthermore, it seems that dietary supplementation with this alga might enhance systemic pool of tetrapyrroles, known to be higher in subjects with Gilbert syndrome.


Asunto(s)
Antineoplásicos/farmacología , Bilirrubina/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias Pancreáticas/patología , Extractos Vegetales/farmacología , Spirulina , Tetrapirroles/farmacología , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Humanos , Técnicas In Vitro , Ratones , Ratones Desnudos , Oxidación-Reducción , Neoplasias Pancreáticas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Trasplante Heterólogo , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Fitoterapia ; 82(5): 786-91, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21545828

RESUMEN

This work studied a relationship between HO-1/CO system and lipid peroxidation with consequent effects on liver functions and NOS-2. We focused on curcumin pretreatment in rat toxic model of d-galactosamine and lipopolysaccharide. Hepatocyte viability, lipid peroxidation, antioxidant status, ALT and AST were evaluated. HO-1 and NOS-2 expressions and respective enzyme activity were determined. Curcumin caused decreases in ALT and AST levels as well as in lipid peroxidation. Furthermore, curcumin pretreatment increased liver HO-1 (2.4-fold, p=0.001), but reduced NOS-2 (4.1-fold, p=0.01) expressions. In conclusion, the tuning of CO/NO pathways is important in shedding light on curcumin's cytoprotective effects in this model.


Asunto(s)
Antioxidantes/uso terapéutico , Monóxido de Carbono/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Curcumina/uso terapéutico , Hemo-Oxigenasa 1/metabolismo , Hígado/efectos de los fármacos , Fitoterapia , Alanina Transaminasa/sangre , Animales , Antioxidantes/farmacología , Aspartato Aminotransferasas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Curcuma/química , Curcumina/farmacología , Modelos Animales de Enfermedad , Galactosamina , Peroxidación de Lípido/efectos de los fármacos , Lipopolisacáridos , Hígado/citología , Hígado/metabolismo , Masculino , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Wistar , Transducción de Señal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA